Antigenic polypeptides
AssigneesThe University of Sheffield, Biosynexus Incorporated
InventorsSimon Foster, James Mond, Simon Clarke, Philip McDowell, Kirsty Brummel
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for the identification of antigenic polypeptides, typically opsonic antigens, expressed by pathogenic microbes; vaccines comprising said antigens; and therapeutic antibodies directed to said antigenic polypeptides.
Claims19
An antigenic polypeptide, or part thereof, encoded by an isolated DNA molecule selected from the group consisting of:
- (i) a DNA molecule of SEQ ID NO.:
- 57;
- (ii) a DNA molecule which hybridizes to the DNA molecule identified in (i) which encodes a polypeptide expressed by a pathogenic organism;
- and
- (iii) a DNA molecule which is 85% or more homologous to the DNA sequence defined in (i) or (ii).
An antigenic polypeptide according to claim 4 wherein the Staphylococcus sp is Staphylococcus aureus or Staphylococcus epidermidis.
A method of generating an immune response in an animal against a pathogenic microbe, the method comprising administering to said animal a polypeptide of SEQ ID NO.:
- 244.
A method for preparing a hybridoma cell-line producing an antibody, the method comprising the steps of:
- i) immunizing an immunocompetent mammal with an immunogenic comprising at least one polypeptide having an amino acid sequence selected from the group consisting of SEQ ID NOS.:
- 123-424, or an antigenic fragment thereof;
- ii) fusing lymphocytes of the immunized immunocompetent mammal with myeloma cells to form hybridoma cells;
- iii) culturing the hybridoma cells to proliferate and to secrete said monoclonal antibody;
- iv) screening monoclonal antibodies produced by the hybridoma cells of step (ii) for binding activity to the amino acid sequences of (i).
A method according to 17, further comprising:
- recovering the antibody.
Dependencies are inferred from the claim text.